ArticleOncotarget2015

CCL2 is transcriptionally controlled by the lysosomal protease cathepsin S in a CD74-dependent manner.

Richard D A Wilkinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.